| 08.15 |
Welcome and Opening |
| |
Cancer Stem Cells
Chair: Pier Giuseppe Pelicci
Rapporteur: Giuseppina Bonizzi |
| 08.30 |
Mammary stem and progenitor cells:
understanding the cellular context of
breast tumours – John Stingl |
| 08.45 |
Relevance of the molecular identity of
human normal breast stem cells to
the heterogeneity of breast cancers – Salvatore Pece |
| 09.00 |
Stem and progenitor cells as signposts for therapeutic targets in breast cancer - Geoff Lindeman |
| 09.15 |
Discussion |
| |
New molecules for
chemoprevention
Chair: Bernardo Bonanni
Rapporteur: Aliana Guerrieri Gonzaga |
| 09.25 |
Can you teach an old dog new tricks?:
Vitamin D and breast cancer prevention – Pamela Goodwin |
| 09.40 |
Endocrine therapies for prevention – Andrea
Decensi |
| 09.55 |
Evaluating new targets for novel
approaches in prevention – Nicole Karen Johnson |
| 10.10 |
Discussion |
| 10.20 |
Coffee Break |
| 10.50 |
Spotlight:
Diet: is it important for breast cancer
prevention? Peter Boyle |
| |
New imaging for screening
Chair: Enrico Cassano
Rapporteur: Francesca Abbate |
| 11.10 |
Relying on ultrasound – Giorgio
Rizzatto |
| 11.25 |
Improved breast imaging with MRI:
is it ready for screening? – Elizabeth
A. Morris |
| 11.40 |
Long term results of women submitted
to intensive yearly control –
Patrick Maisonneuve |
| 11.55 |
Discussion |
| 12.05 |
Live Surgery with commentary
Speaker: Mattia Intra |
| 13.00 |
Lunch |
| |
Breast surgery: innovations
Chair: Umberto Veronesi
Rapporteur: Oreste Gentilini |
| 14.00 |
Optimizing surgical approaches for
multifocal and multicentric cancers:
the nipple sparing mastectomy – Umberto Veronesi |
| 14.15 |
Radioguided surgical treatment of
non palpable tumours – Alberto Luini |
| 14.30 |
Outcome of treatment of very early
carcinomas – Stefano Zurrida |
| 14.45 |
Discussion |
| 14.55 |
Spotlight:
Is breast cancer surgery becoming
more conservative or more radical? – Hiram S. Cody III |
| |
Pathology
Chair: Giuseppe Viale
Rapporteur: Mauro Mastropasqua |
| 15.15 |
DIN 1, 2, 3 – Farid Moinfar |
| 15.30 |
Triple negative & basal like - Ian Ellis |
| 15.45 |
Lymphoma of the breast – Giancarlo
Pruneri |
| 16.00 |
Salivary type & other rare types – Vincenzo Eusebi |
| 16.15 |
Discussion |
| 16.30 |
Coffee Break |
| 17.00 |
Special Spotlight:
“Is adjuvant chemotherapy needed
and for whom? – Stefan Aebi
“How to approach data from past
trials for the best adjuvant treatment
choice in the present? –
Richard D. Gelber
Closing remarks: Eric Winer
|
| 17.40 |
Satellite Symposia |
HOME PAGE
Wed, 17 june 2009
Additional Activities